Insights Widest with the analysis, Proactive gives perspectives that others don't.

scientist at petrie dish Midatech Pharma sees big 18 months ahead as clinical trials build momentum

Here we take a closer look at Midatech Pharma PLC (LON:MTPH)

1 day, 19 hours ago
Deep dive

Allergy Therapeutics:Profitable, growing and with strong product pipeline

As the name suggests, Allergy Therapeutics PLC, which is headquartered in Worthing, West Sussex...

2 days, 19 hours ago

One less Dave and one less Willie: Departure of Tesco and IAG bosses raises...

Despite yet more FTSE 100 CEOs calling time in the board room, Britain's biggest companies...

1 week, 3 days ago
Deep dive

Circassia Pharmaceuticals plots a path to profitability

It currently markets two products: NIOX, which is used to help manage asthma, and Tudorza, a...

1 week, 3 days ago
Deep dive

Integumen's digital revolution builds momentum

Here we take a closer look at Integumen PLC, which has developed and digitised an artificial skin

1 week, 3 days ago


Full interview: Revenue guidance from OptiBiotix as it eyes NASDAQ listing

OptiBiotix Health (LON:OPTI) provides a commercial progress update, explaining why in their financials some items are separated. CEO Stephen O'Hara tells Proactive London what's behind his thinking adding that Optibiotix hopes to reach profitability in 2020. News here too on Sweetbiotix and...

1 day, 14 hours ago

Join Proactive

Get ahead of the curve

First with the equities news

Get our market previews and stories before the main networks.

Widest with the analysis

Not just the FTSE. Read about
opportunities from the whole
equities market.

Closest to the source

Hear directors at first-hand
or meet them in person at our events.

In at the start

Watch IPOs and access on the same terms as the institutions.